Mark Pearson (EQH) Exercises 27,200 Options; Sells 39,700 Shares Under 10b5-1
Rhea-AI Filing Summary
Mark Pearson, President and CEO of Equitable Holdings, Inc. (EQH), executed option exercises and share sales under a 10b5-1 plan. On 08/18/2025 he exercised 27,200 employee stock options at an exercise price of $23.18, creating an immediate beneficial ownership figure shown as 742,729 shares. On the same date he sold a total of 39,700 shares in multiple trades at weighted average prices of $53.0407 and $53.5998, with reported post-transaction ownership levels of 703,538 and 703,029 shares. The Form 4 states the exercise and sales were effected pursuant to a Rule 10b5-1 trading plan adopted May 16, 2025, and that reported ownership includes Restricted Stock Units.
Positive
- Transactions executed under a Rule 10b5-1 plan, indicating a pre-established trading arrangement adopted May 16, 2025
- Exercise of 27,200 employee stock options at a stated exercise price of $23.18, converting equity compensation to owned shares
- Detailed disclosure of weighted average sale prices and willingness to provide trade-level information upon request
Negative
- Insider sold 39,700 shares on 08/18/2025, reducing beneficial ownership to 703,029 shares after the transactions
Insights
TL;DR: Insider exercised options and sold shares under a pre-established 10b5-1 plan; disclosure appears compliant and routine.
The reporting shows an exercise of 27,200 employee stock options at $23.18 and contemporaneous sales totaling 39,700 shares executed under a 10b5-1 plan adopted May 16, 2025. The Form 4 includes weighted average sale prices and an undertaking to provide trade-level details upon request, which aligns with transparent insider reporting practices. The filing discloses inclusion of Restricted Stock Units in beneficial ownership and specifies the option grant and vesting schedule. From a governance perspective, the pre-established plan and explicit explanations reduce regulatory and information asymmetry concerns.
TL;DR: Insider liquidity event via option exercise and share sales; net holdings remain sizable but sales reduce immediate stake.
The exercise of 27,200 options at $23.18 followed by sales at weighted averages near $53.04 and $53.60 realize intrinsic value while leaving the reporting person with over 700,000 shares beneficially owned. The filing quantifies post-transaction ownership as 703,029 shares after the final sale. These transactions convert option upside into cash and modestly reduce the insider's share count; the filing does not include any extraordinary items or change in control indicators. For investors, this is a liquidity event rather than a signal of company-level operational change.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Employee Stock Option (right to buy) | 27,200 | $0.00 | -- |
| Exercise | Common Stock | 27,200 | $23.18 | $630K |
| Sale | Common Stock | 39,191 | $53.0407 | $2.08M |
| Sale | Common Stock | 509 | $53.5998 | $27K |
Footnotes (1)
- The sales reported and options exercised on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 16, 2025. Includes Restricted Stock Units. This transaction was executed in multiple trades at prices ranging from $52.5650 to $53.5649 The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was affected. This transaction was executed in multiple trades at prices ranging from $53.5650 to $53.6400. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was affected. Grant of employee stock option under the Issuer's 2019 Omnibus Incentive Plan exempt under Rule 16b-3. The options vested in three installments beginning on February 26, 2021.
